Gene · 8929
Papers1,813
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 1,813
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Making neurons, made easy: The use of Neurogenin-2 in neuronal differentiation. | Stem Cell Reports | 2022 | 34971564 | PubTator, text mining | PubMed |
| Advancing genomic technologies and clinical awareness accelerates discovery of disease-associated tandem repeat sequences. | Genome Res | 2022 | 34965938 | PubTator, text mining | PubMed |
| A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era. | Cancer Discov | 2022 | 34921008 | PubTator, text mining | PubMed |
| Inhibition of anandamide hydrolysis does not rescue respiratory abnormalities observed in an animal model of Parkinson's disease. | Exp Physiol | 2022 | 34907627 | PubTator, text mining | PubMed |
| Beyond the Retrotrapezoid Nucleus in Congenital Central Hypoventilation Syndrome. | Am J Respir Crit Care Med | 2022 | 34905719 | PubTator, text mining | PubMed |
| Probing the multimodal fungiform papilla: complex peripheral nerve endings of chorda tympani taste and mechanosensitive fibers before and after Hedgehog pathway inhibition. | Cell Tissue Res | 2022 | 34859291 | PubTator, text mining | PubMed |
| An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy. | J Exp Med | 2022 | 34812843 | PubTator, text mining | PubMed |
| Implication and Influence of Multigene Panel Testing with Genetic Counseling in Korean Patients with BRCA1/2 Mutation-Negative Breast Cancer. | Cancer Res Treat | 2022 | 34793666 | PubTator, text mining | PubMed |
| Peptide-Centric CAR-T Cells Target Unmutated Intracellular Oncoproteins. | Cancer Discov | 2022 | 34772735 | PubTator, text mining | PubMed |
| EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma. | Cancer Discov | 2022 | 34772733 | PubTator, text mining | PubMed |
| The expression of PHOX2B in bone marrow and peripheral blood predicts adverse clinical outcome in non-high-risk neuroblastoma. | Pediatr Hematol Oncol | 2022 | 34752187 | PubTator, text mining | PubMed |
| Human embryonic stem cell-derived neural crest model unveils CD55 as a cancer stem cell regulator for therapeutic targeting in MYCN-amplified neuroblastoma. | Neuro Oncol | 2022 | 34655293 | PubTator, text mining | PubMed |
| GLP-1 physiology informs the pharmacotherapy of obesity. | Mol Metab | 2022 | 34626851 | PubTator, text mining | PubMed |
| Comparison of three different methods to detect bone marrow involvement in patients with neuroblastoma. | J Cancer Res Clin Oncol | 2022 | 34623519 | PubTator, text mining | PubMed |
| Children with Congenital Central Hypoventilation Syndrome Do Not Wake up to Ventilator Alarms. | Sleep Breath | 2022 | 34506013 | PubTator, text mining | PubMed |
| Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma. | Br J Cancer | 2022 | 34471258 | PubTator, text mining | PubMed |
| Refractory Stage M Ganglioneuroblastoma With Bone Metastases and a Favorable, Chronic Course of Disease: Description of a Patient Cohort. | J Pediatr Hematol Oncol | 2022 | 33885033 | PubTator, text mining | PubMed |
| Structure analysis of the proteins associated with polyA repeat expansion disorders. | J Biomol Struct Dyn | 2022 | 33459170 | PubTator, text mining | PubMed |
| Prediction of histopathological local staging by radiological findings and differential diagnosis overview in children with nephroblastoma. | Rom J Morphol Embryol | 2021 | 35673813 | PubTator, text mining | PubMed |
| Deep analysis of neuroblastoma core regulatory circuitries using online databases and integrated bioinformatics shows their pan-cancer roles as prognostic predictors. | Discov Oncol | 2021 | 35201514 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8929/papers?page=27